ChatGPT logoOur pick
A
8.8/10

ChatGPT

VS
GPT-Rosalind (OpenAI) logo
C
6.8/10

GPT-Rosalind (OpenAI)

ChatGPT vs GPT-Rosalind (OpenAI)

Tier-list head-to-head. ChatGPT takes the A-tier slot — here's the breakdown.

Last reviewed April 24, 2026· sweep-fresh

Spec sheet

At a glance

 ChatGPT logoChatGPTGPT-Rosalind (OpenAI) logoGPT-Rosalind (OpenAI)
TierA-tierwinC-tier
Overall score8.8 / 10win6.8 / 10
Free tierYeswinNo
Starting price$0Invite only
Best forEveryone.Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacen…
Last reviewed2026-04-242026-04-17

Head-to-head

Score showdown

Rated 1-10 on the same rubric across all 130 tools we cover.

Ease of use+7.0 ChatGPT
ChatGPT
10.0
GPT-Rosalind (OpenAI)
3.0
Output quality+1.0 GPT-Rosalind (OpenAI)
ChatGPT
8.0
GPT-Rosalind (OpenAI)
9.0
Value+1.0 ChatGPT
ChatGPT
8.0
GPT-Rosalind (OpenAI)
7.0
Features+1.0 ChatGPT
ChatGPT
9.0
GPT-Rosalind (OpenAI)
8.0
Overall+2.0 ChatGPT
ChatGPT
8.8
GPT-Rosalind (OpenAI)
6.8

What you'll pay

Pricing snapshot

Look past the headline number -- entry-tier limits drive most cost surprises.

ChatGPT logo

ChatGPT

Free tier available

  • Free$0
  • Go$8/mo
  • Plus$20/mo
GPT-Rosalind (OpenAI) logo

GPT-Rosalind (OpenAI)

No free tier

  • Trusted Access (gated)Invite only
  • Life Sciences Codex PluginIncluded with ChatGPT Pro / Business
  • Public accessNot available

Benchmark Head-to-Head

GPT-5.5 (launched 2026-04-23; scores below are the GPT-5.4 baseline -- GPT-5.5 launch benchmarks per OpenAI are logged in Known Issues, pending third-party verification) benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks

BenchmarkScore
MMLU91%
GPQA Diamond92.8%
AIME 202483.3%
HumanEval95%
SWE-bench72%
ARC-AGI73.3%

The decision

Which should you pick?

Use-case anchors and category strengths, side by side.

Our pick
ChatGPT logo

Pick ChatGPTif…

A
8.8/10
  • Easier to learn and use day-to-day -- friendlier onboarding curve
  • Better value at the price you'll actually pay (8.0/10 on value)
  • More feature surface area for power users who'll use the depth
  • Free tier lets you actually try it before paying
  • Seriously -- if you're new to AI or want the most complete all-in-one package, ChatGPT is the default recommendation.

Everyone. Seriously -- if you're new to AI or want the most complete all-in-one package, ChatGPT is the default recommendation.

Visit ChatGPT
GPT-Rosalind (OpenAI) logo

Pick GPT-Rosalind (OpenAI)if…

C
6.8/10
  • Higher output quality (9.0 vs 8.0) where polish matters more than speed
  • Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access.
  • Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Bottom line

The verdict

ChatGPT is the clear winner: 8.8/10 (A-tier) versus 6.8/10 (C-tier). GPT-Rosalind (OpenAI) isn't a bad tool, but on every category that drives the overall score, ChatGPT comes out ahead. The tier gap is repeatable -- not methodology noise -- and the day-to-day experience reflects it.

On pricing, ChatGPT starts free while GPT-Rosalind (OpenAI) requires a paid plan from day one (Invite only+). If you're testing the waters or running an occasional workload, that gap matters more than the score differential. ChatGPT starts at $0; GPT-Rosalind (OpenAI) starts at Invite only. Compare what each entry tier actually unlocks before you compare list prices -- the limits matter more than the headline number.

By use case: pick ChatGPT when everyone. Pick GPT-Rosalind (OpenAI) when researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access. The two tools aren't fighting for the same person -- they're aiming at adjacent jobs that occasionally overlap. If you're squarely in ChatGPT's lane, the tier-list ranking and the use-case fit point the same direction; if you're in GPT-Rosalind (OpenAI)'s lane, the score gap matters less than the fit.

Bottom line: ChatGPT is the better tool for most people right now. Pick GPT-Rosalind (OpenAI) only when researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access -- that's its lane, and inside that lane it still earns its place.

AIToolTier verdictLast reviewed April 24, 2026Tier rubric · ease of use, output, value, features

Keep digging

Compare more & explore

Built from our daily AI-tool sweep, last touched April 24, 2026. Honest tier-list reviews — no affiliate-link pieces disguised as advice. See the rubric or how we review.